Free US Court of Appeals for the Third Circuit case summaries from Justia.
If you are unable to see this message, click here to view it in a web browser. | | US Court of Appeals for the Third Circuit April 23, 2020 |
|
|
Click here to remove Verdict from subsequent Justia newsletter(s). | New on Verdict Legal Analysis and Commentary | Rethinking Retroactivity in Light of the Supreme Court’s Jury Unanimity Requirement | MICHAEL C. DORF | | In light of the U.S. Supreme Court’s decision Monday in Ramos v. Louisiana, in which it held that the federal Constitution forbids states from convicting defendants except by a unanimous jury, Cornell law professor Michael C. Dorf discusses the Court’s jurisprudence on retroactivity. Dorf highlights some costs and benefits of retroactivity and argues that the Court’s refusal to issue advisory opinions limits its ability to resolve retroactivity questions in a way that responds to all the relevant considerations. | Read More |
|
US Court of Appeals for the Third Circuit Opinions | In re: Lamictal Direct Purchaser Antitrust Litigation | Docket: 19-1655 Opinion Date: April 22, 2020 Judge: Thomas L. Ambro Areas of Law: Antitrust & Trade Regulation, Class Action, Drugs & Biotech | GSK’s patent to an anti-epilepsy drug, Lamictal, was to expire in 2009. Teva sought to market a generic version of Lamictal, lamotrigine, before GSK’s patent expired. Teva submitted an Abbreviated New Drug Application. GSK sued for infringement. After Teva received a favorable ruling with respect to one claim in 2005, the parties settled. Teva would begin selling lamotrigine six months before it could have had GSK won but later than if it had succeeded in litigation. GSK promised not to launch an authorized generic (AG) version of Lamictal. Had the parties not settled and had Teva succeeded in litigation, it would have been entitled to a 180-day exclusivity period as the generic first filer but GSK could have launched an AG. Companies that directly purchased Lamictal or lamotrigine (Direct Purchasers) sued, claiming the settlement violated the antitrust laws because GSK “paid” Teva to stay out of the market by promising not to launch an AG, resulting in Direct Purchasers paying more than they would have otherwise. The district court certified a class of all companies that purchased Lamictal from GSK or lamotrigine from Teva. The Third Circuit vacated. The district court certified the class without undertaking the required “rigorous” analysis, failing to resolve key factual disputes, assess competing evidence, and weigh conflicting expert testimony, all of which bear heavily on the predominance requirement, and confused injury with damages. | | Ali v. Woodbridge Township School District | Docket: 19-2217 Opinion Date: April 22, 2020 Judge: Greenaway Areas of Law: Civil Rights, Constitutional Law, Education Law, Labor & Employment Law | Ali, a non-practicing Muslim of Egyptian descent, was a non-tenured high school teacher. His supervisor received complaints about Ali’s instruction on the Holocaust. One English teacher reported that her students were questioning historical accounts of the Holocaust, opining that Hitler didn’t hate the Jews and that the death counts were exaggerated. Students’ written assignments confirmed those accounts. Ali also presented a lesson on the September 11 terrorist attacks, requiring students to read online articles translated by the Middle Eastern Media Research Institute (MEMRI). Ali posted links to the articles on a school-sponsored website: “U.S. Planned, Carried Out 9/11 Attacks—But Blames Others” and “U.S. Planning 9/11 Style Attack Using ISIS in Early 2015.” The MEMRI articles also contained links to other articles, such as “The Jews are Like a Cancer, Woe to the World if they Become Strong.” A reporter questioned Principal Lottman and Superintendent Zega. Lottman directed Ali to remove the MEMRI links from the school’s website. The following morning, Ali met with Zega and Lottman; his employment was terminated. Ali sued under New Jersey law and 42 U.S.C. 1981, claiming that Lottman referred to him as “Mufasa,” asked Ali if “they had computers in Egypt,” and remarked on his ethnicity during the meetings that resulted in Ali’s termination. He alleged discrimination, hostile work environment, free speech and academic freedom violations, and defamation. The Third Circuit affirmed summary judgment in favor of the defendants. Ali cannot show that his termination for teaching anti-Semitic views was a pretext for discrimination. | |
|
About Justia Opinion Summaries | Justia Daily Opinion Summaries is a free service, with 68 different newsletters, covering every federal appellate court and the highest courts of all US states. | Justia also provides weekly practice area newsletters in 63 different practice areas. | All daily and weekly Justia newsletters are free. Subscribe or modify your newsletter subscription preferences at daily.justia.com. | You may freely redistribute this email in whole. | About Justia | Justia is an online platform that provides the community with open access to the law, legal information, and lawyers. |
|
|